Expanding the clinical features of autoinflammation and phospholipase Cγ2-associated antibody deficiency and immune dysregulation by description of a novel patient.
Journal
Journal of the European Academy of Dermatology and Venereology : JEADV
ISSN: 1468-3083
Titre abrégé: J Eur Acad Dermatol Venereol
Pays: England
ID NLM: 9216037
Informations de publication
Date de publication:
Dec 2019
Dec 2019
Historique:
received:
19
06
2019
accepted:
21
08
2019
pubmed:
30
8
2019
medline:
28
5
2020
entrez:
30
8
2019
Statut:
ppublish
Résumé
Autoinflammation and phospholipase Cγ2-associated antibody deficiency and immune dysregulation (APLAID) is an exceedingly rare monogenic autoinflammatory disease. To date, only five cases have been reported with four distinct pathogenic mutations. We present a novel case of APLAID, corroborated by molecular analysis, with newly described clinical findings including central nervous system vasculitis (CNSV); and distinctive histopathological characteristics that may expand our knowledge of this rare disease's phenotype. This is a case report presentation of a 3-year-old boy, seen at a reference paediatric hospital in Mexico. His parents authorized the use of his clinical information and photographs. A 3-day-old boy presented to the emergency department with a vesiculo-pustular rash that resolved within 1 week. Two months later, he developed widespread papules and pseudovesicles that evolved into infiltrated plaques. He also had periodical flares of conjunctivitis, diarrhoea and erythematous blistering acral plaques triggered by upper respiratory infections. By the age of 10 months, he experienced seizures and CNSV. Laboratory work-up showed mild neutropenia, decreased serum levels of immunoglobulins and B-cell lymphopenia. A skin biopsy revealed a dense, perivascular and interstitial histiocytic and granulomatous infiltrate, with palisading granulomas, and leucocytoclastic vasculitis with karyorrhexis. APLAID syndrome was confirmed by Sanger sequencing of PLCG2 gene [heterozygous genotype LRG_376t1:c.2543T>C or p.(Leu848Pro)]. Presence of CNSV has not been previously described in APLAID, however as the number of reported patients with APLAID is very small, it is possible that the overall spectrum of clinical manifestations has not been completely elucidated. The herein identified p.(Leu848Pro) variant was also documented in a Portuguese patient, suggesting that it could be a PLCG2 gene 'hot-spot'.
Sections du résumé
BACKGROUND
BACKGROUND
Autoinflammation and phospholipase Cγ2-associated antibody deficiency and immune dysregulation (APLAID) is an exceedingly rare monogenic autoinflammatory disease. To date, only five cases have been reported with four distinct pathogenic mutations.
OBJECTIVES
OBJECTIVE
We present a novel case of APLAID, corroborated by molecular analysis, with newly described clinical findings including central nervous system vasculitis (CNSV); and distinctive histopathological characteristics that may expand our knowledge of this rare disease's phenotype.
METHODS
METHODS
This is a case report presentation of a 3-year-old boy, seen at a reference paediatric hospital in Mexico. His parents authorized the use of his clinical information and photographs.
RESULTS
RESULTS
A 3-day-old boy presented to the emergency department with a vesiculo-pustular rash that resolved within 1 week. Two months later, he developed widespread papules and pseudovesicles that evolved into infiltrated plaques. He also had periodical flares of conjunctivitis, diarrhoea and erythematous blistering acral plaques triggered by upper respiratory infections. By the age of 10 months, he experienced seizures and CNSV. Laboratory work-up showed mild neutropenia, decreased serum levels of immunoglobulins and B-cell lymphopenia. A skin biopsy revealed a dense, perivascular and interstitial histiocytic and granulomatous infiltrate, with palisading granulomas, and leucocytoclastic vasculitis with karyorrhexis. APLAID syndrome was confirmed by Sanger sequencing of PLCG2 gene [heterozygous genotype LRG_376t1:c.2543T>C or p.(Leu848Pro)].
CONCLUSIONS
CONCLUSIONS
Presence of CNSV has not been previously described in APLAID, however as the number of reported patients with APLAID is very small, it is possible that the overall spectrum of clinical manifestations has not been completely elucidated. The herein identified p.(Leu848Pro) variant was also documented in a Portuguese patient, suggesting that it could be a PLCG2 gene 'hot-spot'.
Substances chimiques
Phospholipase C gamma
EC 3.1.4.3
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2334-2339Subventions
Organisme : Recursos Fiscales del Programa E022
ID : E022
Informations de copyright
© 2019 European Academy of Dermatology and Venereology.
Références
McGonagle D, McDermott MF. A proposed classification of the immunological diseases. PLoS Med 2006; 3: e297.
Hernández-Ostiz S, Prieto-Torres L, Xirotagaros G et al. Autoinflammatory diseases in pediatric dermatology-part 1: urticaria-like syndromes, pustular syndromes, and mucocutaneous ulceration syndromes. Actas Dermosifiliogr 2017; 108: 609-619.
Zhou Q, Lee GS, Brady J et al. A hypermorphic missense mutation in PLCG2, encoding phospholipase Cγ2, causes a dominantly inherited autoinflammatory disease with immunodeficiency. Am J Hum Genet 2012; 91: 713-720.
Neves JF, Doffinger R, Barcena-Morales G et al. Novel PLCG2 mutation in a patient With APLAID and cutis laxa. Front Immunol 2018; 9: 2863.
Tassi I, Cella M, Casto I et al. Requirement of phospholipase C-gamma2 (PLCgamma2) for Dectin-1-induced antigen presentation and induction of TH1/TH17 polarization. Eur J Immunol 2009; 39: 1368-1378.
Xu S, Huo J, Lee KG et al. Phospholipase Cgamma2 is critical for Dectin-1-mediated Ca2 + flux and cytokine production in dendritic cells. J Biol Chem 2009; 284: 7038-7046.
Fu G, Chen Y, Schuman J et al. Phospholipase Cy2 plays a role in TCR signal transduction and T cell selection. J Immunol 2012; 189: 2326-2332.
Yu P, Constien R, Dear N et al. Autoimmunity and inflammation due to a gain-of-function mutation in phospholipase C gamma 2 that specifically increases external Ca2 + entry. Immunity 2005; 22: 451-465.
Chae JJ, Park YH, Park C et al. Connecting two pathways through Ca 2 + signaling: NLRP3 inflammasome activation induced by a hypermorphic PLCG2 mutation. Arthritis Rheumatol 2015; 67: 563-567.
Torrelo A, Vera A, Portugués M et al. Perforating neutrophilic and granulomatous dermatitis of the newborn-a clue to immunodeficiency. Pediatr Dermatol 2007; 24: 211-215.
Martin-Nalda A, Fortuny C, Mensa-Vilaró A et al. Autoinflammation, antibody deficiency and immune dysregulation in two unrelated patients due to novel and de novo PLCγ2 mutation. In: Annual Meeting of European Society for Immunodeficiencies 2017; Sept 11-14. Edinburgh. URL https://esid2017.kenes.com/Documents/ESID17_all_abstracts-usb.pdf (last accessed: 16 July 2019).
Ombrello MJ, Remmers EF, Sun G et al. Cold urticaria, immunodeficiency, and autoimmunity related to PLCG2 deletions. N Engl J Med 2012; 366: 330-338.
Milner JD. PLAID: a syndrome of complex patterns of disease and unique phenotypes. J Clin Immunol 2015; 35: 527-530.
Aderibigbe OM, Priel DL, Lee CC et al. Distinct cutaneous manifestations and cold-induced leukocyte activation associated with PLCG2 mutations. JAMA Dermatol 2015; 151: 627-634.
Crow YJ, Casanova JL. STING-associated vasculopathy with onset in infancy-a new interferonopathy. N Eng J Med 2014; 371: 568-571.
Navon EP, Pierce SB, Segel R et al. Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy. N Eng J Med 2014; 470: 921-931.
Caorsi R, Penco F, Schena F, Gattorno M. Monogenic polyarteritis: the lesson of ADA2 deficiency. Pediatr Rheumatol Online J 2016; 14: 51.
Jain A, Misra DP, Sharma A et al. Vasculitis and vasculitis-like manifestations in monogenic autoinflammatory syndromes. Rheumatol Int 2018; 38: 13-24.